Steris (STE) Misses Q1 EPS by 2c ; Offers Guidance

Steris (NYSE: STE) reported Q1 EPS of $2.83, $0.02 worse than the analyst estimate of $2.85. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.59 billion.

GUIDANCE:

Steris sees FY2026 EPS of $11.10-$11.30, versus the consensus of $10.20.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• RBC Capital Resumes BorgWarner (BWA) at Outperform
• Goldman Sachs sees refinery exemptions boosting DK cash flow